Full-Time

Clinical Research Associate 2

Posted on 5/8/2026

Syneos Health

Syneos Health

10,001+ employees

Global provider of integrated clinical-to-commercial services

No salary listed

Remote in UK

Remote

Up to 75% travel required; remote in United Kingdom.

Category
Biology & Biotech (1)
Requirements
  • Bachelor’s degree or Registered Nurse in a related field or equivalent combination of education, training and experience
  • Knowledge of Good Clinical Practice/International Conference on Harmonisation Guidelines and other applicable regulatory requirements
  • Must demonstrate good computer skills and be able to embrace new technologies
  • Excellent communication, presentation and interpersonal skills
  • Ability to manage required travel of up to 75% on a regular basis
  • May be deployed to sites that require certain medical and other personal information to gain facility access and you are required to comply with site requests as a condition of employment
Responsibilities
  • Performs site qualification, site initiation, interim monitoring, site management activities and close-out visits (performed on-site or remotely) ensuring regulatory, ICH-GCP and/or Good Pharmacovigilance Practice (GPP) and protocol compliance.
  • Uses judgment and experience to evaluate overall performance of site and site staff and to provide recommendations regarding site-specific actions; immediately communicates/escalates serious issues to the project team and develops action plans.
  • Maintains a working knowledge of ICH/GCP Guidelines or other applicable guidance, relevant regulations, and company SOPs/processes.
  • Verifies the process of obtaining informed consent has been adequately performed and documented for each subject/patient, as required/appropriate.
  • Demonstrates diligence in protecting the confidentiality of each subject/patient.
  • Assesses factors that might affect subject/patient’s safety and clinical data integrity at an investigator/physician site such as protocol deviation/violations and pharmacovigilance issues.
  • Assesses site processes. Conducts Source Document Review of appropriate site source documents and medical records.
  • Verifies required clinical data entered in the case report form (CRF) is accurate and complete.
  • Applies query resolution techniques remotely and on site, and provides guidance to site staff as necessary, driving query resolution to closure within agreed timelines.
  • Utilizes available hardware and software to support the effective conduct of the clinical study data review and capture.
  • Verifies site compliance with electronic data capture requirements.
  • May perform investigational product (IP) inventory, reconciliation and reviews storage and security.
  • Verifies the IP has been dispensed and administered to subjects/patients according to the protocol.
  • Verifies issues or risks associated with blinded or randomized information related to IP.
  • Applies knowledge of GCP/local regulations and organizational procedures to ensure IP is appropriately (re)labelled, imported and released/returned.
  • Routinely reviews the Investigator Site File (ISF) for accuracy, timeliness and completeness.
  • Reconciles contents of the ISF with the Trial Master File (TMF).
  • Ensures the investigator/physician site is aware of the requirement of archiving essential documents in accordance with local guidelines and regulations.
  • Documents activities via confirmation letters, follow-up letters, trip reports, communication logs, and other required project documents as per SOPs and Clinical Monitoring Plan/Site Management Plan.
  • Supports subject/patient recruitment, retention and awareness strategies.
  • Enters data into tracking systems as required to track all observations, ongoing status and assigned action items to resolution.
  • For assigned activities, understands project scope, budgets, and timelines; manages site-level activities / communication to ensure project objectives, deliverables and timelines are met.
  • Must be able to quickly adapt to changing priorities to achieve goals / targets.
  • May act as primary liaison with study site personnel, or in collaboration with Central Monitoring Associate.
  • Ensures all assigned sites and project-specific site team members are trained and compliant with applicable requirements
  • Prepares for and attends Investigator Meetings and/or sponsor face to face meetings.
  • Participates in global clinical monitoring/project staff meetings (inclusive of Sponsor representation, as applicable) and attends clinical training sessions according to the project specific requirements.
  • Provides guidance at the site and project level towards audit readiness standards and supports preparation for audit and required follow-up actions.
  • Maintains a working knowledge of ICH/GCP Guidelines or other applicable guidance, relevant regulations, and company SOPs/processes; completes assigned training as required.
  • For Real World Late Phase, the CRA II will use the business card title of Site Management Associate II.
  • Site support throughout the study lifecycle from site identification through close-out.
  • Knowledge of local requirements for real world late phase study designs.Chart abstraction activities and data collection Collaboration with Sponsor affiliates, medical science liaisons and local country staff.
  • The SMA II may be requested to train junior staff.
  • Identify and communicate out of scope activities to Lead CRA/Project Manager.
  • Proactively suggest potential sites based on local knowledge of treatment patterns, patient advocacy and Health Care Provider associations.

Syneos Health provides end-to-end biopharmaceutical solutions across the clinical-to-commercial spectrum. It helps biopharma companies, healthcare organizations, and investors by offering specialized expertise, insights, and technology-enabled services to move therapies faster to patients. Its offerings include Kinetic, a modern omnichannel customer engagement platform that uses targeting and analytics to coordinate nationwide healthcare communications, and Syneos One, an asset development approach that aligns strategy and execution from early concept through commercialization. The company uses AI and advanced tech to improve performance and reduce risk in drug development and market delivery. Its goal is to be a trusted partner that accelerates therapy development and delivery by combining scientific know-how with integrated, data-driven services.

Company Size

10,001+

Company Stage

IPO

Headquarters

Morrisville, North Carolina

Founded

1985

Simplify Jobs

Simplify's Take

What believers are saying

  • KAI Conversations partnership embeds AI conversation intelligence into commercial solutions since April 2026.
  • Bestudy acquisition secures foothold in China's rapidly growing biopharma market.
  • Sunway Healthcare partnership expands clinical trial expertise across Malaysia's therapeutic areas.

What critics are saying

  • Securities class action advances to discovery after March 2026 court denial in SDNY.
  • Abandoning 2016 NC jobs grant triggers government clawbacks within 6-12 months.
  • China Bestudy acquisition halts trials from CFDA inspections in 12-18 months.

What makes Syneos Health unique

  • Syneos Health integrates clinical, real-world evidence, and commercial strategy for end-to-end biopharma solutions.
  • Kinetic platform delivers AI-powered omnichannel customer engagement for healthcare organizations.
  • Syneos One methodology combines asset strategy and execution from concept to commercialization.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Syneos Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Employee Stock Purchase Plan

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Remote Work Options

Company News

Fierce Biotech
Mar 19th, 2026
Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. | North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a foothold in the Asian nation.

PRWeek
May 7th, 2025
Imre hires Greg Voyles as chief growth officer

Voyles joins Imre from Syneos Health, where he served as VP of commercial solutions.

Healthcare Asia Magazine
Dec 2nd, 2024
Sunway Healthcare Group, Syneos Health to expand clinical trial expertise

Sunway Healthcare Group has partnered with Syneos Health to expand clinical trial capabilities across therapeutic areas in Malaysia.

BioSpace
Oct 10th, 2024
Syneos Health Appoints Costa Panagos as Chief Executive Officer

Syneos Health appoints Costa Panagos as chief executive officer.

PRWeek
Oct 7th, 2024
Syneos Health makes senior hires

Syneos has also appointed Jen Husdan as an associate director.